# Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases

> **NCT00006255** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 17 (actual)

## Conditions studied

- Kidney Cancer
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **PROCEDURE:** radiofrequency ablation
- **PROCEDURE:** thermal ablation therapy

## Key facts

- **NCT ID:** NCT00006255
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-04
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006255, "Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00006255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*